MX340963B - Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida. - Google Patents
Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida.Info
- Publication number
- MX340963B MX340963B MX2010011875A MX2010011875A MX340963B MX 340963 B MX340963 B MX 340963B MX 2010011875 A MX2010011875 A MX 2010011875A MX 2010011875 A MX2010011875 A MX 2010011875A MX 340963 B MX340963 B MX 340963B
- Authority
- MX
- Mexico
- Prior art keywords
- ethanolamide
- treatment
- pathologies
- stearoyl
- pharmaceutical formulation
- Prior art date
Links
- HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 title abstract 2
- 229950007031 palmidrol Drugs 0.000 title abstract 2
- 230000007170 pathology Effects 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 239000000443 aerosol Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se relaciona con nuevas formulaciones farmacéuticas que contienen una mezcla de compuestos de palmitoil etanolamida o PEA o estearil etanolamida o SEA como principios activos. La formulación es apropiada para la administración oral, parenteral, tópica, transdérmica, rectal, sublingual, nasal, tópica, transdérmica, rectal, nasal o sublingual, por lo que la forma de dosificación de las formulaciones pueden ser en parches, supositorios, óvulos, pesarios, aerosol o atomización, emulsiones, suspensiones, soluciones. Las formulaciones farmacéuticas son útiles para el tratamiento o prevención de patologías de la piel, para el tratamiento o prevención de patologías ginecológicas para el tratamiento de trastornos o patologías caracterizadas por el metabolismo inapropiado de ácidos grasos así como para el tratamiento de trastornos o patologías caracterizadas por estados inflamatorios.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2008/000292 WO2009133574A1 (en) | 2008-04-28 | 2008-04-28 | Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2010011875A MX2010011875A (es) | 2011-03-29 |
| MX340963B true MX340963B (es) | 2016-07-29 |
Family
ID=40474765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010011875A MX340963B (es) | 2008-04-28 | 2008-04-28 | Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8487007B2 (es) |
| EP (1) | EP2276461B1 (es) |
| CN (1) | CN102014868B (es) |
| AU (1) | AU2008355537B2 (es) |
| BR (1) | BRPI0822603A2 (es) |
| CA (1) | CA2722491C (es) |
| DK (1) | DK2276461T3 (es) |
| ES (1) | ES2529235T3 (es) |
| HK (1) | HK1154521A1 (es) |
| MX (1) | MX340963B (es) |
| PL (1) | PL2276461T3 (es) |
| WO (1) | WO2009133574A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9623000B2 (en) | 2008-07-31 | 2017-04-18 | Dekel Pharmaceuticals Ltd | Compositions and methods for treating inflammatory disorders |
| ITPD20090360A1 (it) * | 2009-12-01 | 2011-06-02 | Vermont Italia Srl | Composizione per uso topico |
| US9309438B2 (en) | 2011-04-05 | 2016-04-12 | ALLNEX Belgium SA | Radiation curable compositions |
| EP2644589A1 (en) | 2012-03-30 | 2013-10-02 | Cytec Surface Specialties, S.A. | Radiation Curable (Meth)acrylated Compounds |
| EP2644634A1 (en) | 2012-03-30 | 2013-10-02 | Cytec Surface Specialties, S.A. | Radiation curable (meth)acrylated compounds |
| DE102014004258A1 (de) * | 2014-03-19 | 2015-09-24 | Bauerfeind Ag | Fasern und Garne mit Okklusionsfunktion |
| DK3297622T3 (da) * | 2015-05-21 | 2024-01-22 | Scisparc Ltd | Kombinationer af oxycodon og n-acylethanolaminpalmitoylethanolamin til reduktion af opioidassocierede bivirkninger |
| IT202000016411A1 (it) * | 2020-07-07 | 2022-01-07 | Performs S R L | Formulazione per veicolare principi attivi lipofili |
| CN115531245A (zh) * | 2022-05-25 | 2022-12-30 | 上海拜思丽实业有限公司 | 一种抗炎修复纳米组合物及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2394833A (en) * | 1942-08-10 | 1946-02-12 | Ind Patents Corp | Wax composition |
| US5506224A (en) * | 1991-12-31 | 1996-04-09 | Lifegroup S.P.A. | N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes |
| AUPN531195A0 (en) * | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
| JP3066018B2 (ja) * | 1998-05-28 | 2000-07-17 | 弘美 真田 | 内圧調整バルブを備えたクッション |
| AU776414B2 (en) * | 1998-05-29 | 2004-09-09 | Neurosciences Research Foundation, Inc. | Control of pain with endogenous cannabinoids |
| WO2008023998A1 (en) * | 2006-08-22 | 2008-02-28 | Industrial Research Limited | N-acylethanolamines as wound healing agents |
| NZ552238A (en) * | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
-
2008
- 2008-04-28 CA CA2722491A patent/CA2722491C/en active Active
- 2008-04-28 WO PCT/IT2008/000292 patent/WO2009133574A1/en active Application Filing
- 2008-04-28 CN CN200880128896.4A patent/CN102014868B/zh not_active Expired - Fee Related
- 2008-04-28 ES ES08763844.1T patent/ES2529235T3/es active Active
- 2008-04-28 US US12/989,786 patent/US8487007B2/en active Active
- 2008-04-28 MX MX2010011875A patent/MX340963B/es active IP Right Grant
- 2008-04-28 DK DK08763844.1T patent/DK2276461T3/en active
- 2008-04-28 AU AU2008355537A patent/AU2008355537B2/en not_active Ceased
- 2008-04-28 BR BRPI0822603-2A patent/BRPI0822603A2/pt not_active Application Discontinuation
- 2008-04-28 EP EP08763844.1A patent/EP2276461B1/en active Active
- 2008-04-28 PL PL08763844T patent/PL2276461T3/pl unknown
-
2011
- 2011-08-25 HK HK11108974.0A patent/HK1154521A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008355537A1 (en) | 2009-11-05 |
| DK2276461T3 (en) | 2015-01-26 |
| AU2008355537B2 (en) | 2014-02-06 |
| HK1154521A1 (en) | 2012-04-27 |
| ES2529235T3 (es) | 2015-02-18 |
| MX2010011875A (es) | 2011-03-29 |
| US8487007B2 (en) | 2013-07-16 |
| CN102014868B (zh) | 2014-11-12 |
| CA2722491C (en) | 2016-09-06 |
| CN102014868A (zh) | 2011-04-13 |
| US20110046225A1 (en) | 2011-02-24 |
| WO2009133574A1 (en) | 2009-11-05 |
| BRPI0822603A2 (pt) | 2015-06-16 |
| EP2276461B1 (en) | 2014-11-26 |
| EP2276461A1 (en) | 2011-01-26 |
| PL2276461T3 (pl) | 2015-03-31 |
| CA2722491A1 (en) | 2009-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010011875A (es) | Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida. | |
| PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
| MX352434B (es) | Formulaciones topicas que tienen biodisponibilidad aumentada. | |
| GEP20156366B (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | |
| GB0625648D0 (en) | Compounds | |
| HK1142062A1 (en) | Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) | |
| MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
| IN2012DN01233A (es) | ||
| MX2009009590A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| MY173994A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| GB0906579D0 (en) | Pharmaceuticals, compositions and methods of making and using the same | |
| ZA200801471B (en) | Process for the hydrogenation of glycerol to propyleneglycol | |
| MX346335B (es) | Composiciones antisentido, y metodos para obtener y usar las mismas. | |
| MX2012004525A (es) | Compuestos. | |
| MX2009011473A (es) | Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas. | |
| WO2008086014A3 (en) | Bis-aryl amide derivatives useful for the treatment of cancer | |
| EP2328550A4 (en) | MUCOADHERENT COMPOSITIONS AND THEIR USE | |
| MY160074A (en) | Protopanaxadiol-type ginsenoside compositions and uses thereof | |
| MX2010000266A (es) | Un método para disminuir los síntomas del consumo de alcohol. | |
| GB2456434A (en) | Buprenorphine-containing non-pressurised spray composition for transmucosal administration | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| IT1396468B1 (it) | Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie. | |
| MX2010002032A (es) | Uso de flibanserina para el tratamiento de sintomas vasomotores. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |